Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1971 Mar;3(3):424–428. doi: 10.1128/iai.3.3.424-428.1971

Interferon System in Cells from Human Tumors and from Persons Predisposed to Cancer

Michael Worthington 1, Stuart A Aaronson 2
PMCID: PMC416169  PMID: 16557991

Abstract

In the present study, the interferon system was evaluated in fibroblasts from persons predisposed to leukemia or other cancers, in fibroblasts from persons with neoplastic disease, and in human tumor cells. Of 31 normal fibroblast strains from patients with tumors or diseases associated with a high incidence of malignancy, only one cell strain had a poor response to either of the two interferon inducers used, polyinosinic-polycytidylic acid and Chikungunya virus. On the other hand, cell cultures of five human tumors were much less sensitive to the antiviral effect of these interferon inducers and of human interferon and produced less interferon in response to Chikungunya virus than any of the nontumor tissues studied.

Full text

PDF
424

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aaronson S. A., Todaro G. J., Freeman A. E. Human sarcoma cells in culture. Identification by colony-forming ability on monolayers of normal cells. Exp Cell Res. 1970 Jul;61(1):1–5. doi: 10.1016/0014-4827(70)90250-8. [DOI] [PubMed] [Google Scholar]
  2. Aaronson S. A., Todaro G. J. Transformation and virus growth by murine sarcoma viruses in human cells. Nature. 1970 Jan 31;225(5231):458–459. doi: 10.1038/225458a0. [DOI] [PubMed] [Google Scholar]
  3. Armstrong D., Paucker K. Effect of mycoplasma on interferon production and interferon assay in cell cultures. J Bacteriol. 1966 Jul;92(1):97–101. doi: 10.1128/jb.92.1.97-101.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brailovsky C. A., Berman L. D., Chany C. Decreased interferon sensitivity and production in cells transformed by SV40 and other oncogenic agents. Int J Cancer. 1969 Mar 15;4(2):194–203. doi: 10.1002/ijc.2910040209. [DOI] [PubMed] [Google Scholar]
  5. CANTELL K., PAUCKER K. Studies on viral interference in two lines of HeLa cells. Virology. 1963 Jan;19:81–87. doi: 10.1016/0042-6822(63)90027-8. [DOI] [PubMed] [Google Scholar]
  6. CHANY C. [An inhibiting factor of intracellular multiplication of viruses called interferon, originating from cancer cells. The phenomenon of viral autoinhibition]. C R Hebd Seances Acad Sci. 1960 Jun 8;250:3903–3905. [PubMed] [Google Scholar]
  7. CLARKE D. H., CASALS J. Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses. Am J Trop Med Hyg. 1958 Sep;7(5):561–573. doi: 10.4269/ajtmh.1958.7.561. [DOI] [PubMed] [Google Scholar]
  8. Chany C., Lemaître J., Grégoire A. Facteurs antagonistes de l'action antivirale de l'interféron extraites de différentes sarcomes humains. C R Acad Sci Hebd Seances Acad Sci D. 1969 Dec 22;269(25):2628–2630. [PubMed] [Google Scholar]
  9. Field A. K., Tytell A. A., Lampson G. P., Hilleman M. R. Inducers of interferon and host resistance. II. Multistranded synthetic polynucleotide complexes. Proc Natl Acad Sci U S A. 1967 Sep;58(3):1004–1010. doi: 10.1073/pnas.58.3.1004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fischinger P. J., O'Connor T. E. Productive infection and morphologic alteration of human cells by a modified sarcoma virus. J Natl Cancer Inst. 1970 Feb;44(2):429–438. [PubMed] [Google Scholar]
  11. Freeman A. E., Uhlendorf C. P., Younkers P. E., Baron S. Responsiveness of normal and transformed rat embryo cell cultures to poly I-poly C and interferon. J Cell Physiol. 1970 Dec;76(3):365–371. doi: 10.1002/jcp.1040760314. [DOI] [PubMed] [Google Scholar]
  12. Gresser I., Bourali C. Antitumor effects of interferon preparations in mice. J Natl Cancer Inst. 1970 Aug;45(2):365–376. [PubMed] [Google Scholar]
  13. HO M., ENDERS J. F. Further studies on an inhibitor of viral activity appearing in infected cell cultures and its role in chronic viral infections. Virology. 1959 Nov;9:446–477. doi: 10.1016/0042-6822(59)90135-7. [DOI] [PubMed] [Google Scholar]
  14. Miller R. W. Persons with exceptionally high risk of leukemia. Cancer Res. 1967 Dec;27(12):2420–2423. [PubMed] [Google Scholar]
  15. Miller R. W., Todaro G. J. Viral transformation of cells from persons at high risk of cancer. Lancet. 1969 Jan 11;1(7585):81–82. doi: 10.1016/s0140-6736(69)91094-0. [DOI] [PubMed] [Google Scholar]
  16. Morton D. L., Hall W. T., Malmgren R. A. Human liposarcomas: tissue cultures containing foci of transformed cells with viral particles. Science. 1969 Aug 22;165(3895):813–816. doi: 10.1126/science.165.3895.813. [DOI] [PubMed] [Google Scholar]
  17. Peries J., Canivet M., Bernard C., Boiron M., Lépine P. Perte de la sensibilité cellulaire à l'action d'un interféron exogène après infection par les virus du complexe leucémies-sarcomes de la souris. C R Acad Sci Hebd Seances Acad Sci D. 1968 Mar 25;266(13):1439–1441. [PubMed] [Google Scholar]
  18. Peries J., Canivet M., Guillemain B., Boiron M. Inhibitory effect of interferon perparation on the development of foci of altered cells induced in vitro by mouse sarcoma virus. J Gen Virol. 1968 Dec;3(3):465–468. doi: 10.1099/0022-1317-3-3-465. [DOI] [PubMed] [Google Scholar]
  19. ROTEM Z., BERWALD Y., SACHS L. INHIBITION OF INTERFERON PRODUCTION IN HAMSTER CELLS TRANSFORMED IN VITRO WITH CARCINOGENIC HYDROCARBONS. Virology. 1964 Nov;24:483–486. doi: 10.1016/0042-6822(64)90189-8. [DOI] [PubMed] [Google Scholar]
  20. SHEIN H. M., ENDERS J. F. Transformation induced by simian virus 40 in human renal cell cultures. I. Morphology and growth characteristics. Proc Natl Acad Sci U S A. 1962 Jul 15;48:1164–1172. doi: 10.1073/pnas.48.7.1164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. STENKVIST B., PONTEN J. MORPHOLOGICAL CHANGES IN BOVINE AND HUMAN FIBROBLASTS EXPOSED TO TWO STRAINS OF ROUS SARCOMA VIRUS IN VITRO. Acta Pathol Microbiol Scand. 1964;62:315–330. doi: 10.1111/apm.1964.62.3.315. [DOI] [PubMed] [Google Scholar]
  22. Sarma P. S., Shiu G., Neubauer R. H., Baron S., Huebner R. J. Virus-induced sarcoma of mice: inhibition by a synthetic polyribonucleotide complex. Proc Natl Acad Sci U S A. 1969 Apr;62(4):1046–1051. doi: 10.1073/pnas.62.4.1046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Singer S. H., Barile M. F., Kirschstein R. L. Enhanced virus yields and decreased interferon production in mycoplasma-infected hamster cells. Proc Soc Exp Biol Med. 1969 Sep;131(4):1129–1134. doi: 10.3181/00379727-131-34053. [DOI] [PubMed] [Google Scholar]
  24. Strander H., Cantell K., Leisti J., Nikkila E. Interferon response of lymphocytes in disorders with decreased resistance to infections. Clin Exp Immunol. 1970 Feb;6(2):263–272. [PMC free article] [PubMed] [Google Scholar]
  25. Todaro G. J., Baron S. The role of interferon in the inhibition of SV40 transformation of mouse cell line 3T3. Proc Natl Acad Sci U S A. 1965 Sep;54(3):752–756. doi: 10.1073/pnas.54.3.752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Todaro G. J., Zeve V., Aaronson S. A. Viruses in cell culture derived from human tumour patients. Nature. 1970 Jun 13;226(5250):1047–1049. doi: 10.1038/2261047a0. [DOI] [PubMed] [Google Scholar]
  27. Yershov F. I., Zhdanov V. M. Influence of PPLO on production of interferon in virus-infected cells. Virology. 1965 Nov;27(3):451–453. doi: 10.1016/0042-6822(65)90132-7. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES